Nalidixic acid CAS:389-08-2
Nalidixic acid is typically administered orally in the form of tablets or capsules. It is essential to follow the dosage instructions provided by a healthcare provider to ensure the proper therapeutic effect. This antibiotic is commonly used for urinary tract infections caused by susceptible bacteria, particularly in cases of uncomplicated cystitis. Patients are advised to take the medication as directed, usually multiple times a day, with or without food. Before initiating treatment with nalidixic acid, healthcare providers may perform susceptibility testing to confirm the presence of susceptible bacteria. Completing the full course of medication is crucial to eradicate the infection completely and prevent the development of resistance. If symptoms persist or worsen during treatment, consult a healthcare professional for further evaluation. It is important to stay hydrated while taking nalidixic acid to support kidney function and ensure optimal drug clearance. Adverse effects such as gastrointestinal disturbances or allergic reactions may occur, and patients should promptly report any unexpected symptoms to their healthcare provider. Proper storage of nalidixic acid in a cool, dry place away from direct sunlight is necessary to maintain its stability and efficacy. Consulting a healthcare professional for guidance on the appropriate use of nalidixic acid is recommended for the effective management of urinary tract infections.
Composition | C12H12N2O3 |
Assay | 99% |
Appearance | white powder |
CAS No. | 389-08-2 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |